 Fosfestrol was patented in 1941 and was introduced for medical use in 1955.It was previously marketed widely throughout the world, but now remains available in only a few countries.Fosfestrol is used as a form of high-dose estrogen therapy in the treatment of castration-resistant prostate cancer.